Lean Enterprise Institute Announces Mark Reich as Keynote Speaker at Lean Summit 2025, March 5, 2025

by

BOSTON, MA – February 5, 2025—The Lean Enterprise Institute (LEI) is pleased to announce that Mark Reich, Senior Coach and Chief Engineer of Strategy at LEI, will deliver a keynote speech and lead a panel discussion at the upcoming Lean Summit 2025. The event will take place March 5 and 6, 2025, at the Renaissance Atlanta Waverly Hotel & Convention Center, 2450 Galleria Parkway, Atlanta, Georgia, 30339, USA.

Reich will give the keynote address at 9:30 a.m., followed by a keynote panel on which he will host Marcia Brey, Vice President of Logistics at GE Appliances; Charles F. Murphy, Senior Vice President at Turner Construction Company, the leading general builder in the US; Geoff Miller, CEO of Grand Rapids Chair; and an executive from Nucleus Software.

“I’m thrilled that we have such a diverse group of international businesses represented on the panel, including small and large consumer goods manufacturers, construction, and software,” notes Reich. Adding, “It shows how lean thinking and hoshin kanri can be applied to just about any business or use case.”

Reich, author of the highly anticipated book Managing on Purpose, out on March 5 as well, will share insights on implementing hoshin kanri, a core component of lean management systems. His presentation will focus on aligning organizational strategy with daily operations to drive sustainable growth and foster a culture of continuous improvement.

Event Highlights

Keynote Speech:
Mark Reich will discuss key concepts from his new book and offer practical strategies for leaders to enhance their organizations’ performance.

Panel Discussion:
Reich will lead Brey and Murphy in exploring real-world applications of lean principles across various sectors.

Book Launch:
Managing on Purpose will be officially released at the summit, and copies will be available for purchase and signing.

About Mark Reich
Mark Reich has over 23 years of experience with Toyota, where he was the process owner of hoshin kanri for North America. As a senior coach at LEI, he has collaborated with numerous business leaders to implement lean practices, including developing and executing hoshin kanri in their organizations. His unique perspective makes Managing on Purpose a vital resource and a practical toolkit for aspiring leaders.

About the Lean Summit 2025
The Lean Summit 2025 is LEI’s flagship event. It brings together leaders and practitioners from diverse industries to share knowledge and best practices in lean thinking and methodologies. For more information about the Lean Summit 2025 or to register, please visit https://events.lean.org/event/cbccfabf-1519-4cd2-ae7c-cc2000844719/overview-lean-summit-2025.

About the Lean Enterprise Institute
The Lean Enterprise Institute Inc. is a nonprofit based in Boston, MA, with a mission to make things better by advancing lean thinking and practice. It fulfills its mission by publishing books, instructing workshops, hosting conferences, partnering with companies, and issuing free content on its website, www.lean.org.

Modus Cooperandi Press Announces Amazon Bestselling Release of D. Lynn Kelley with John Shook’s Change Questions

by

Detroit, Michigan – August 2, 2023 – Modus Cooperandi Press’ change management book Change Questions by noted executive D. Lynn Kelley, PhD, with prominent Lean Management expert John Shook, was released with an event at Aretha’s Jazz Cafe here last night and is already an Amazon bestseller ranking number 1 in the categories of Lean Management, Agile Project Management, and Business Structural Adjustment.

The pace of organizational change has been increasing. Unfortunately, most change activities fail to deliver anticipated results, and those that do often fail to sustain. The Change Questions book addresses these critical issues by providing a proven process with a strong record of sustainment that can be used by anyone responsible for implementing organizational change.

The book includes a case study with examples and stories of transformation at Fortune 200 company Union Pacific Railroad over eight years. Using the Change Questions at Union Pacific resulted in a dramatic increase in operational performance and a 96% sustainment rate over hundreds of change initiatives.

The Change Questions represent a new way of thinking and acting characterized by an investigative process that creates a situational and customized approach to change. Whether the reader is a professional, a student, or someone asked to lead a significant organizational change for the first time, this framework is easily used to implement change that sustains successfully. The book includes meeting timelines, deliverables, and sample agendas. A digital workbook that is a self-guided tool for implementing change can be accessed by purchasing the book.

Author D. Lynn Kelley is currently a Senior Advisor to Brown Brothers Harriman Capital Partners and is actively involved in sourcing, investment evaluation, and providing post-investment value-added oversight to their portfolio companies. She was the senior vice president of Supply Chain and Continuous Improvement at Union Pacific Railroad from 2010-18. Earlier, Lynn worked at Textron, where she was vice president of Operational Excellence and was a member of the Executive Leadership Team. She had international responsibilities across all business units, including Cessna Aircraft and Bell Helicopter.

Lynn holds a PhD from Wayne State University in Evaluation and Research, an MBA from Michigan State University, and a B.S. in Business Management from the University of Detroit-Mercy. Lynn completed post-doctoral fellowships at the US Census Bureau and the American Society of Engineering Education. She has published 17 articles and three books on statistics and operational excellence.

John Shook learned about lean management while working for Toyota for 11 years in Japan and the U.S., helping it transfer production, engineering, and management systems from Japan to NUMMI and other operations worldwide. While at Toyota’s headquarters, he became the company’s first American manager in Japan. In the U.S., Shook joined Toyota’s North American engineering, research, and development center in Ann Arbor, Michigan as general manager of administration and planning. His last position with Toyota was as senior American manager with the Toyota Supplier Support Center in Lexington, Kentucky, assisting North American companies in adopting the Toyota Production System.

Shook co-authored Learning to See, which introduced the world to value-stream mapping. He also co-authored Kaizen Express, a bi-lingual manual of the essential concepts and tools of the Toyota Production System. With Managing to Learn, Shook revealed the deeper workings of the A3 management process at the heart of Toyota’s management and leadership.

GOAT Male American Ski Racer Bode Miller Partners with Affordable Natural Homebuilding Startup Geoship

by

Bode Miller photo: Geoship Create the Futre You Imagine
Nevada City, CA/Big Sky, MT – May 2, 2023 – The most successful American male ski racer of all time, Bode Miller, has become an investor and strategic advisor in Geoship — to address the climate-housing challenge and help people live closer to nature and community — starting in mountain towns.

Miller notes, “I was raised off the grid, in the solitary nature of the woods. So much of who I am today is the direct result of my upbringing. Now as the father of eight, I want my kids to have similar experiences. In 2019 Morgan and I chose to move our family to Montana. Many have expressed a desire to do the same with their own families. Unfortunately for many, this lifestyle is out of reach due to the recent rapid rise in housing prices. Perhaps it is time to start thinking outside of the box to make mountain living more accessible to families. I’m excited to partner with Geoship to address the climate-housing challenge in a way that will help people live closer to nature and community — starting in mountain towns.”

Geoship founder and CEO Morgan Bierschenk adds, “Bode and I are dads on a mission to raise our kids closer to nature and village life. Geoship is more than a new construction technology — we’re building an economic engine for the regenerative village future. Whether winning six Olympic medals or being a father of eight — Bode is a force of nature and puts 100% into what he does. So, it’s an honor to begin this journey with Bode, to remove some of the barriers families face in building homes in harmony with nature.”

Geoship’s ‘first principles’ approach to home manufacturing combines the most efficient geometry and material science with 21st-century manufacturing technology. Nature’s strongest structure, the geodesic dome, is combined with a breakthrough in bioceramic materials — enabling healthy natural homes that cost half as much as conventional homes, have a 90% smaller carbon footprint, and have a design life of 500 years.

Bioceramic domes are combined with a digital space for communities to form and democratize the village design/build process. Villages are distinct from housing developments in that they’re cultural places designed and built with community participation. Geoship is transitioning into a multi-stakeholder cooperative — customers and nature stewards will own up to 50% of the company. This combination of a revolutionary housing product, business model, and ownership structure enables deep impact on a level never before possible.

The company is continuing towards its ‘Earthshot’: To make the best home on earth, the most affordable one, and scale manufacturing to one million ceramic domes per year. The recently revealed prototype is the world’s first ceramic dome.

Bierschenk concludes, “Our Nevada City prototype dome has attracted interest from architects, artists, engineers, developers, and dome lovers from over 60 countries. Thanks to platforms like Republic and Wefunder, the right to invest in world-changing private tech companies is no longer limited to accredited investors. We invite skiers, snowboarders, mountain communities, artists, climate advocates, impact investors, and nature lovers to join Bode Miller and our crew of over 2,000 visionary impact investors in building a more beautiful world.

###

About Geoship SPC:
Geoship SPC is a leading innovator in next-generation homes, featuring a unique combination of eco-friendly ceramic materials and geodesic dome structures. The company grew from the vision of its two founders, Morgan Bierschenk and Bas Kools, to address some of the greatest challenges of our time: affordable housing, climate change, chronic disease, and social isolation. Investment information for Geoship’s current funding round can be found at Republic.com/Geoship (see terms and conditions at republic.com) or www.Geoship.is.

About Bode Miller:
Father, Husband, Learner, and Teacher. Winner of six Olympic Alpine skiing medals. Co-Founder @peakskis

Retention Focus for Sports Betting Brands after Super Bowl LVI

by

Keeping customers active to prevent attrition is key to growth

Gzira, Malta – February 10, 2022 – With the number of U.S. states legalizing online sports betting growing at a fast pace over the last year, online gambling brands will be keen to attract new players ahead of Super Bowl LVI on February 14th. However, customer service experts Enteractive say that retention of new players will be key to maintaining growth in the current gold rush to build a loyal customer base.

“While sportsbook operators are spending large sums on licensing, promotion, marketing, and competitive odds to prompt fast growth as they enter these new markets in the U.S., they must keep a focus on retention of all those hard-won customers,” says Mikael Hansson, founder of Enteractive, a company which provides loyalty and engagement services for the online gambling industry, contacting players on behalf of sports betting brands with more personal one-to-one phone calls.

Following last month’s successful launch of mobile sports gambling services in New York, it’s clear that there’s a large appetite amongst US consumers for the growing number of online sportsbooks. In a YouGov survey from January 2021, almost 20% of Americans said they like to wager on the Super Bowl, with 77% betting purely on the outcome of the game.

In 2022, with so many more states now offering legalized mobile sports betting, sportsbook operators can expect to see increased registrations from new customers around Super Bowl LVI, but while this increased interest is good for business, successful growth will depend upon those new customers remaining active, rather than ‘churning’ after big events like the Super Bowl are over.

“There’s currently a gold rush in the U.S. sports betting market,” adds Hansson, “and the eventual winners will be those brands that engage with their customers and build relationships for the future. Every brand in this sector must keep a clear focus on all aspects of their offering, ensuring that all the hard work in getting to market is not quickly lost to the competition.”

Ei.Ventures and Orthogonal Thinker Acquire 12×12 Estate in The Sandbox in Anticipation of PSLY.COM Launch Post-Merger with Mycotopia Therapies in Q1 2022

by

Miami, Florida – January 4, 2022 – Ei.Ventures, along with Orthogonal Thinker, is excited to announce the acquisition of a 12×12 estate in The Sandbox, a virtual world where players can build, own, and monetize their gaming experiences on the Ethereum blockchain. This purchase represents the third-largest land sale in the Metaverse and is valued at $2.22M. The land will be called PSLY.COM, the name of the soon-to-be merged company of Ei.Ventures with Mycotopia Therapies.

After only a week on the platform, Ei.Ventures and Orthogonal Thinker CEO David Nikzad was ready to invest in a legacy project for the combined companies’ vision of psychedelic therapy and move into the Metaverse over the next 36 months, noting, “The combination of our tech, cannabis, psychedelics, outer space, and crypto-related holdings will all be utilizing this exciting space. We are very excited to invite all of our portfolio companies and investors to be part of something extraordinary.”

Ei.Ventures now owns 144 pieces of Sandbox land that make up this 12×12 estate. Their neighbors include noted companies like Axie Infinity, SANDBOX, Binance, and many others. PSLY.COM is now right in the middle of these disruptive giants.

While the exact plans for the PSLY.COM Sandbox space are still in development, expect wondrous VR experiences of Hawaii, positive psychedelic trips, healing modalities, and much more.

Nikzad adds, “As I remember my early days as an investor going to Y Combinator, it was about looking at things that were 10B disruptive. Health and Wellness is a trillion-dollar market. As we’ve now gone through COVID and are still in the craziness of it, these technologies will become much more important as communications and how financial transactions are handled is changing,” and ends with thanks to “Blockchain.com, MetaMask, NFTTRADER, and all the individuals and teams, including Ei’s co-founders, that came together to execute this transaction.”

Mycotopia CEO Benjamin Kaplan adds, “as we are working to close our merger with Ei.Ventures, we are so heartened by the forward-thinking moves Ei is making to set up PSLY.COM for success in the Metaverse and beyond.”

Ei.Ventures Closes Out an Exciting 2021, Heads into 2022 Leading the Way in Psychedelic Medicine Development, Fundraising and more

by

Miami, Florida – December 15, 2021 – First and foremost the Ei.Ventures’ Reg A+ raise has been incredible. Support from investors from all over the country has topped expectations. As it stands, Ei.Ventures has raised $19,914,863 of a $50 million qualification.

With new studies emerging showing that microdosing psychedelics has a clear association with fewer symptoms of depression, anxiety, and stress, it’s no wonder there is such a desire to see Ei.Ventures’ Psilly and other psychedelic medicines hit the mainstream.

And as of last week Ei.Ventures announced some exciting news regarding its Go Public pathway: the company signed an LOI with Mycotopia (TPIA) to explore a merger and the formation of PSLY.COM, a $360 million transaction, and will apply to list shares on NASDAQ. More info about the potential merger and anticipated NASDAQ listing is available here. Ei.Ventures CEO David Nikzad notes, “This is a very exciting deal that provides more certainty in a “Go Public” path forward and disrupts the typical investment-banker run going-public model which is often full of bumps and headwinds. Ei.Ventures anticipates closing on the merger in March 2022, assuming we reach a definitive agreement.”

Part of Ei.Ventures’ business strategy has been to develop revenue producing products and partnerships while the novel psychedelic medicines move down the clinical pathway and into legal jurisdictions. On that front the company has been working on three key partnerships over the past few months.

The first joint venture partnership is with The3RDBevCo out of New York. The3RDBevCo is focused on creating first to market functional beverages into the $110 billion global functional drink market. The3RDBevCo will produce the Psilli line of functional mushroom drinks. Psilli will come in five unique blends that target energy, immune support, sleep, cognition, and mood. Interested beverage and mushroom fans can register to win a lifetime supply on launch in late Q1 of 2022 and learn more about Psilli here.

Ei.Ventures also made progress on the clinical development front, with an engagement with Tioga Labs, a premier transdermal research and development company with US offices in San Diego, a noted biotech hub. Tioga has secured the required DEA credentials to handle psychedelic drugs, and has acquired the raw materials to begin development and testing of a transdermal delivery system. Forbes covered the engagement here.

In conjunction with the development of this novel transdermal formulation, Ei.Ventures has also signed a non-binding LOI with RYAH, a connected device, big data, and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry. RYAH has developed a smart patch technology that would further enhance the transdermal delivery system.
The proposed collaboration is expected to:

  • Assess the compatibility of the RYAH Smart Patch delivery and monitoring device, software, and data platform with Ei.Ventures’ proprietary psychedelic formulations
  • Further Ei.Ventures’ research and development strategy, accelerating use testing on controlled delivery and monitoring of psychoactive compounds for mental wellness treatments
  • Position the companies toward a commercial licensing arrangement to deliver psychedelic therapies, in anticipation of governmentally approved treatment options for mental healthcare

There is more info about the LOI here.

In addition to these, Ei.Ventures is working on finalizing an additional partnership with a biotech company focused on developing novel bio synthetic psychedelic materials. This would allow rapid production of botanical psilocin for the current clinical development at an incredibly low cost.

It would also allow pursuit of additional novel patents and IP within the space at a rapid pace. As such Fox Rothschild has been engaged as counsel for further IP development and filings.

The company anticipates that three other very major initiatives will be announced soon.
Ei.Ventures CEO David Nikzad concludes, “As 2021 comes to a close we would like to wish all in the psychedelic, startup, and investment communities, along with our new friends in the South Florida business community, who have been so incredibly welcoming, a wonderful holiday season and a fantastic new year in 2022.”

Ei.Ventures Partners With The3rdBevCo for PSILLI™, a line of Mushroom Infused Functional Sparkling Waters

by

Ronkonkoma, New York/Miami, Florida – November 17, 2021 – Noted medicinal and supplemental mushroom research and development company Ei.Ventures has partnered with rising functional beverage company The3rdBevCo on the first ever line of mushroom infused sparkling waters, called PSILLI™. The line is targeted to be available to wholesalers in late Q1 2022 and to the general public shortly thereafter.

The3rdBevCo CEO Peter Scalise notes, ““I must say meeting the founding team of Ei.Ventures really gives credence to the phrase first impressions are the most important. We immediately hit it off with a working chemistry I never experienced before. We share the same vision, path forward and are laser focused in achieving our goals. Get ready because we are about to bring to market a whole new category in the functional beverage sector unlike anything seen to date that is sure to be the talk of the entire industry from distributors to consumers.”

PSILLI™ is a perfect addition to The3rdBevCo’s growing product range of functional beverages, which include the energy drink line LAID™, CDB energy shot Chill’d™, and ProsecGO™ for those looking for a non-alcoholic experience of Prosecco.

As scientists are discovering, not only are most of the claims about medicinal mushrooms true, but they’re often also safer and better tolerated with fewer side-effects than many modern pharmaceuticals. With PSILLI™, functional mushrooms will be available to
The3rdBevCo’s nationwide base of retailers, bars, restaurants, nightclubs, and event venues, allowing everyone to experience mushrooms’ positive effects.

Functional mushrooms are nutritional powerhouses with a myriad of health benefits including immune support, antioxidants, anti-inflammatory, blood sugar management, brain health and cognition support, nervous system support, and increased energy and stamina.

PSILLI™ will use a variety of mushroom types to create five distinct formulations: Brain Boost to support cognitive and immune function; Study Buddy, a Nootropic supplement; Energizer, a natural energy enhancer; Good Mood a mood optimizer and appetite moderator; and Bedtime, for relaxing.

PSILLI™ will be packaged in the popular 12 ounce slim can and come in five amazing flavors – Black Cherry, Mixed Berry, Blood Orange, Pineapple Hibiscus, Pomegranate Watermelon. With no sugar, zero carbs and only 10 calories in each can, PSILLI™ will be functional and delicious!

Ei.Ventures CEO David Nikzad notes, “We’re so excited to partner with The3rdBevCo on the PSILLI™ line of functional beverages, as they are a leader in the space and can help us spread understanding of the value of mushrooms through the enormous beverage channel. Once people start to use functional mushrooms, they’ll be eager to try the other supplemental mushroom products, and eventually medicinal products that we are bringing to market.”

David Nikzad’s Noted “Utopian Holding Company” Orthogonal Thinker Has Relocated to Miami to Lead for the Future

by

Miami, Florida – November 1, 2021 – Orthogonal Thinker, a self-described “Utopian Holding Company” led by noted investor and exec David Nikzad, is pleased to announce its move to the hottest new venture market – Miami, Florida. This move has invigorated the company, leading to 15 new deals inked since he arrived in early July. Orthogonal makes strategic investments and joint-ventures with companies which contribute to the Orthogonal eco-system of companies in new and emerging industries.

Nikzad, founder and CEO of Orthogonal Thinker notes, “Part of the secret of my success is that I’m just enough ahead of the curve, and my recent move to Miami is just another example of that. We are so excited to be part of the growth of the South Florida startup scene, which is so inclusive of the verticals we specialize in – space, crypto, cannabis, psychedelics, and clean food.”

Orthogonal’s most exciting company is their subsidiary Ei.Ventures. Ei has had an amazing year, cresting $20M committed with their Reg A. As part of their research and development into natural psychedelic compounds, EI recently announced via Forbes that they have partnered with transdermal delivery powerhouse Tioga Research to develop a transdermal patch for sustained delivery of psilocin, the active ingredient in psilocybin mushrooms, for mental health applications.

As part of Ei’s dual track approach, they are planning to launch their line of functional mushroom MANA nutraceuticals imminently, and a functional beverage with mushroom botanicals in early 2022.

Building companies through crowdfunding has always been part of Orthogonal’s DNA, as some early investments included crowdfunders WeFunder, RealCrowd, DealMaker, and Republic. Through this experience and the recent success of Ei’s Reg A, Orthogonal is now positioned as a leader in the Reg A fundraising space and have vertically integrated their internal team to manage Reg A raises for their portfolio companies.

Nikzad adds, “We couldn’t be more bullish on Miami and are looking to show our gratitude for the wonderful reception we’ve gotten in South Florida by bringing funding from all levels of investors to this growing region.”

Emotional Intelligence Ventures Reg A Raise at $20M, Company Pursues Psylocibin Transdermal Delivery Research, Plans Nutraceutical Mushroom Supplements Launch

by

Miami, Florida – October 18, 2021 – Emotional Intelligence Ventures, led by noted investor and exec David Nikzad, are pleased to announce their Regulation A raise is currently at $20,114,949, with more investors coming in daily. Ultimately, they are looking to raise a maximum of $49,999,999, and believe this is a completely doable goal. A Regulation A offering allows for retail investors to invest in pre-public and private companies. The net proceeds of the offering will be used to accelerate the development and distribution of Ei’s medicinal and functional mushroom product lines.

David Nikzad, founder and CEO of Ei.Ventures notes, “We are so committed to the nonaccredited investor, that we are pursuing a Regulation A offering.” Adding, “As I’ve been fortunate to invest early in numerous companies like Airbnb, Betterment, and Vidyard, and three equity crowdfunding platforms (WeFunder, RealCrowd, Republic), I’m really passionate about democratizing investment opportunities so any investor can reap the rewards, and take all of the risks of early investment in game-changing companies.”

As part of their research and development into natural psychedelic compounds, EI recently announced via Forbes that they have partnered with transdermal delivery powerhouse Tioga Research to develop a transdermal patch for sustained delivery of psilocin, the active ingredient in psilocybin mushrooms, for mental health applications.

The company believes this announcement along with the increasing interest in the psychedelic medicine for mental health space, and a rising tide of medicalization, decriminalization, and legalization of psychedelic mushrooms are driving interest in the overall psychedelic medicine space, and Ei.Ventures in particular.

On Monday October 4, the Seattle City Council voted to decriminalize the non-commercial possession and cultivation of many psychedelics, including mushrooms, for “religious, spiritual, healing, or personal growth practices.” Council members passed the resolution unanimously, with a 9-0 vote. This makes Seattle the largest city in the United States to decriminalize psychedelic plants and fungi.

As part of Ei’s dual track approach, they are planning to launch their line of functional mushroom MANA nutraceuticals in early 2022. They are creating proprietary formulations using a unique formulation process for enhanced bioavailability and efficacy. These products target cognition and immune system; energy, vitality, mood, sleep, and weight loss; mental and physical optimization for micro dosers; nootropic or Smart Drugs; and joint & muscle pain.

Ei.Ventures Announce Engagement With Tioga Research to Develop Transdermal Patch for Psilocin Delivery

by

Maui, Hawaii/San Diego, California – August 26, 2021 – Noted psychedelic medicine start-up Ei.Ventures is excited to announce their engagement with Tioga Research to develop a transdermal patch for sustained delivery of psilocin, the active ingredient in psilocybin mushrooms, for mental health applications.

David Nikzad, the CEO of Ei.Ventures notes, “we are over the moon to join with one of the top transdermal delivery research specialists, Tioga Research, to begin developing products that could potentially help millions of people manage their mental health issues – depression, anxiety, PTSD, etc. with a patch. Additionally, with the increasing legality and popularity of psilocybin mushrooms, transdermal delivery could become a popular method for micro-dosing which helps with mental clarity and mood stabilization as well.”

John M. Newsam, CEO of Tioga Research adds, “By working with Ei.Ventures on a blue sky project of this nature, we will deploy our proprietary technologies and deep expertise to address key psilocin formulation issues, such as delivery and stability. A transdermal delivery route can circumvent issues with oral administration, such as nausea.”

EI.Ventures is focused on developing botanical active pharmaceutical ingredients for the psychedelic supply chain, novel psychedelic compounds for various indications, and unique delivery mechanisms and treatment protocols. In addition to their future regulated psychedelic line, Ei Ventures will release their MANA range of functional mushroom nutraceuticals for improving well-being and health in Q3 2021.

Tioga Research supports the research and early development of skin-applied products, offering formulation innovation, skin permeation screening, and GLP IVRT/IVPT services. In addition, the company has pioneered high throughput experimentation (“HTE”) technologies for screening skin delivery. Tioga Research was founded in 2011 to support innovations in skin-applied products, especially topical and transdermal drug products, including skincare products and cosmetics. With headquarters and laboratory operations in San Diego, CA, and a business presence in the UK to support clients in Europe, Tioga Research has become a preferred service provider for an impressive portfolio of clients across the Americas, Europe, and Asia. Tioga Research has been a subsidiary of Encube Ethicals since early 2020, enabling clients to leverage the combined strengths of both organizations from early formulation innovation to commercial manufacturing.